| Code | 3366E | ||||||||||
| MA number | 27/0091/23-S | ||||||||||
| Product Form: | sol inf 7x10 ml (liek.inj.skl.) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | AbbVie s.r.o., Slovakia | ||||||||||
| Therapeutic Class: | 27 - ANTIPARKINSONICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 20 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Subcutaneous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 17.04.2023 |
| Validity: | 17.04.2028 |
| Dokument: |
Duodopa_prirucka pre pacienta_infuzia.pdf
|
| SPC: |
SPC_Duodopa SC_01_2024.pdf
|
| PIL: |
PIL_Duodopa SC_01_2024.pdf
|
| Dokument: |
Duodopa_Príručka pre pacienta_infuzia.pdf
|
| Safety feature | Yes |
| Data update: | 21.04.2023 |
